| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PMS1 RNF213 MCM4 UPF1 DNAH7 HELB ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 2.58e-07 | 441 | 133 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 ATP6V1E1 RNF213 MCM4 UPF1 DNAH7 HELB UBA7 ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 7.08e-07 | 614 | 133 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.05e-04 | 37 | 133 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.16e-04 | 38 | 133 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS1 RNGTT RNF213 MCM4 UPF1 DNAH7 HELB ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 1.48e-04 | 839 | 133 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS1 RNGTT RNF213 MCM4 UPF1 DNAH7 HELB ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 1.50e-04 | 840 | 133 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS1 RNGTT RNF213 MCM4 UPF1 DNAH7 HELB ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 1.50e-04 | 840 | 133 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS1 RNF213 MCM4 UPF1 DNAH7 HELB ATAD3C ABCC8 ATAD2B ASCC3 ATP1A3 ABCD2 CARNS1 DHX34 DYNC1H1 | 2.06e-04 | 775 | 133 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA helicase activity | 7.78e-04 | 62 | 133 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 8.38e-04 | 28 | 133 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | lipoteichoic acid binding | 9.05e-04 | 7 | 133 | 2 | GO:0070891 | |
| Domain | AAA | 6.56e-07 | 144 | 128 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 6.56e-07 | 144 | 128 | 9 | IPR003593 | |
| Domain | L_dom-like | ERBB4 PRAMEF20 INSR CHADL NLRP6 PKD1 LRRC56 PRAME LRRC15 LRRC17 GP1BA | 1.62e-05 | 328 | 128 | 11 | IPR032675 |
| Domain | Nck-associated_protein-1 | 4.66e-05 | 2 | 128 | 2 | IPR019137 | |
| Domain | Nckap1 | 4.66e-05 | 2 | 128 | 2 | PF09735 | |
| Domain | ARM-type_fold | UBQLN1 APC2 WDFY4 MAP3K1 ITPR2 PPP2R1B AP2A2 FHOD1 NUP188 TANGO6 | 1.16e-04 | 339 | 128 | 10 | IPR016024 |
| Domain | REJ | 2.77e-04 | 4 | 128 | 2 | PS51111 | |
| Domain | REJ_dom | 2.77e-04 | 4 | 128 | 2 | IPR014010 | |
| Domain | TBC | 3.51e-04 | 49 | 128 | 4 | SM00164 | |
| Domain | - | 3.72e-04 | 321 | 128 | 9 | 3.80.10.10 | |
| Domain | Cys-rich_flank_reg_C | 3.86e-04 | 90 | 128 | 5 | IPR000483 | |
| Domain | LRRCT | 3.86e-04 | 90 | 128 | 5 | SM00082 | |
| Domain | RabGAP-TBC | 4.75e-04 | 53 | 128 | 4 | PF00566 | |
| Domain | Rab-GTPase-TBC_dom | 5.48e-04 | 55 | 128 | 4 | IPR000195 | |
| Domain | TBC_RABGAP | 5.48e-04 | 55 | 128 | 4 | PS50086 | |
| Domain | Ubiquilin | 6.87e-04 | 6 | 128 | 2 | IPR015496 | |
| Domain | PKD/REJ-like | 6.87e-04 | 6 | 128 | 2 | IPR002859 | |
| Domain | REJ | 6.87e-04 | 6 | 128 | 2 | PF02010 | |
| Domain | Recep_L_domain | 9.57e-04 | 7 | 128 | 2 | PF01030 | |
| Domain | Furin-like | 9.57e-04 | 7 | 128 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 9.57e-04 | 7 | 128 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 9.57e-04 | 7 | 128 | 2 | IPR006211 | |
| Domain | - | 9.57e-04 | 7 | 128 | 2 | 3.80.20.20 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 OR5M10 RNGTT TAS1R3 RNF213 NFASC ITPR2 TMEM260 MYO15B ATAD2B PKD1 XXYLT1 CPSF1 NUP188 DYNC1H1 GP1BA | 2.76e-08 | 736 | 134 | 16 | 29676528 |
| Pubmed | EPPK1 NCKAP1 APC2 PHB2 NFASC BCKDHA UPF1 ITPR2 UBR5 CDH2 ARHGAP21 CEP170B | 1.19e-07 | 430 | 134 | 12 | 32581705 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 EPPK1 TBC1D25 CNTROB ITPR2 PLCD3 GDPD5 LMX1B EIF2B3 PKD1 XXYLT1 LRRC56 CPSF1 NUP188 DHX34 ARHGAP21 CEP170B DYNC1H1 | 2.70e-07 | 1105 | 134 | 18 | 35748872 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 NCKAP1 WDR33 PHB2 MCM4 UPF1 BUD23 FARSA UBR5 SLC25A13 NUP188 UQCRC1 ASCC3 DYNC1H1 | 6.24e-07 | 704 | 134 | 14 | 29955894 |
| Pubmed | NCKAP1 APC2 PHB2 NFASC GRIK3 UPF1 TENM2 FARSA AP2A2 UBR5 CDK5RAP2 CDH2 ARHGAP21 CEP170B DYNC1H1 LRRC15 | 1.02e-06 | 963 | 134 | 16 | 28671696 | |
| Pubmed | ATP6V1E1 INSR PHB2 UPF1 FARSA SLC25A13 NUP188 UQCRC1 ASCC3 CDH2 DYNC1H1 | 2.99e-06 | 484 | 134 | 11 | 31995728 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCKAP1 MAT2A PHB2 MCM4 UPF1 BUD23 PLCD3 AP2A2 UBR5 FHOD1 SLC25A13 EIF2B3 CPSF1 UQCRC1 DHRS2 ASCC3 DHX34 DYNC1H1 | 4.76e-06 | 1353 | 134 | 18 | 29467282 |
| Pubmed | HSPG2 EPPK1 MAT2A PHB2 RNF213 MCM4 MAP3K1 FARSA ATAD3C AP2A2 SLC25A13 UQCRC1 DHRS2 DYNC1H1 | 5.13e-06 | 844 | 134 | 14 | 25963833 | |
| Pubmed | 6.58e-06 | 10 | 134 | 3 | 16805797 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 9.06e-06 | 264 | 134 | 8 | 32814769 | |
| Pubmed | EPPK1 NCKAP1 MCM4 UPF1 UBR5 SLC25A13 ATAD2B CPSF1 NUP188 UQCRC1 ASCC3 DYNC1H1 | 9.11e-06 | 653 | 134 | 12 | 22586326 | |
| Pubmed | Protein kinase D activation stimulates the transcription of the insulin receptor gene. | 1.47e-05 | 2 | 134 | 2 | 20674666 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 34837397 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28077374 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 7643388 | ||
| Pubmed | HSPG2 UBQLN1 UBQLN4 ZNF251 PLCD3 AP2A2 UBR5 TBC1D1 PKD1 ASCC3 DYNC1H1 | 1.94e-05 | 591 | 134 | 11 | 15231748 | |
| Pubmed | 2.31e-05 | 43 | 134 | 4 | 19077034 | ||
| Pubmed | MAT2A PHB2 MCM4 BCKDHA UPF1 RSBN1 FARSA AP2A2 SLC25A13 KLHL12 NUP188 DYNC1H1 | 2.56e-05 | 725 | 134 | 12 | 27025967 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.65e-05 | 150 | 134 | 6 | 30154076 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.28e-05 | 94 | 134 | 5 | 21542922 | |
| Pubmed | Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein. | 3.66e-05 | 17 | 134 | 3 | 20970343 | |
| Pubmed | PMS1 FAT4 EPPK1 MCM4 UPF1 CNTROB UBR5 SLC25A13 CPSF1 ARHGAP21 DYNC1H1 TANGO6 | 3.74e-05 | 754 | 134 | 12 | 35906200 | |
| Pubmed | 3.76e-05 | 322 | 134 | 8 | 26514267 | ||
| Pubmed | 4.37e-05 | 18 | 134 | 3 | 18664271 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20923779 | ||
| Pubmed | Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. | 4.41e-05 | 3 | 134 | 2 | 25643582 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 23798419 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 31919993 | ||
| Pubmed | Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome. | 4.41e-05 | 3 | 134 | 2 | 33048444 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 23828042 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | P4HA2 RNGTT NCKAP1 PHB2 MCM4 TBC1D25 BCKDHA NXN MAP3K3 AP2A2 TBC1D1 EIF2B3 AIPL1 UQCRC1 PRAME DYNC1H1 | 5.17e-05 | 1321 | 134 | 16 | 27173435 |
| Pubmed | 5.18e-05 | 19 | 134 | 3 | 34988124 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | P4HA2 ATP6V1E1 MAT2A MCM4 UPF1 FARSA ATAD3C AP2A2 UQCRC1 ATP1A3 DYNC1H1 | 5.65e-05 | 665 | 134 | 11 | 30457570 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 5.97e-05 | 344 | 134 | 8 | 36282215 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 6.28e-05 | 175 | 134 | 6 | 25756610 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 6.40e-05 | 256 | 134 | 7 | 35777956 | |
| Pubmed | 6.97e-05 | 110 | 134 | 5 | 14667819 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UBQLN1 NCKAP1 UBQLN4 PHB2 UPF1 FARSA UBR5 EIF2B3 XXYLT1 NUP188 ASCC3 ATP1A3 DYNC1H1 | 7.53e-05 | 942 | 134 | 13 | 31073040 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | MAT2A PHB2 MCM4 FARSA AP2A2 UBR5 SLC25A13 NUP188 UQCRC1 DYNC1H1 | 7.78e-05 | 571 | 134 | 10 | 37167062 |
| Pubmed | Large-scale cDNA transfection screening for genes related to cancer development and progression. | 8.26e-05 | 114 | 134 | 5 | 15498874 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 18694874 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.80e-05 | 4 | 134 | 2 | 10469592 | |
| Pubmed | Herp enhances ER-associated protein degradation by recruiting ubiquilins. | 8.80e-05 | 4 | 134 | 2 | 18307982 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 29274231 | ||
| Pubmed | Regulation of insulin-like growth factor receptors by Ubiquilin1. | 8.80e-05 | 4 | 134 | 2 | 29054976 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 37052755 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 21383163 | ||
| Pubmed | NCKAP1 MAT2A ROR2 PHB2 MCM4 UPF1 FARSA SLC25A13 ASCC3 ARHGAP21 DYNC1H1 | 9.84e-05 | 708 | 134 | 11 | 39231216 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RNGTT MAT2A PHB2 MCM4 BCKDHA UPF1 PPP2R1B FARSA UBR5 SLC25A13 CPSF1 NUP188 ASCC3 PRAME DYNC1H1 | 1.06e-04 | 1257 | 134 | 15 | 37317656 |
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 1.07e-04 | 24 | 134 | 3 | 24023788 | |
| Pubmed | 1.20e-04 | 197 | 134 | 6 | 31620119 | ||
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 1.26e-04 | 66 | 134 | 4 | 24811749 | |
| Pubmed | ATP6V1E1 NCKAP1 PHB2 NFASC UPF1 ITPR2 FARSA ATAD3C AP2A2 UQCRC1 ATP1A3 CDH2 SLC25A23 ARHGAP21 CEP170B DYNC1H1 | 1.31e-04 | 1431 | 134 | 16 | 37142655 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.34e-04 | 67 | 134 | 4 | 21875946 | |
| Pubmed | PHB2 RNF213 BCKDHA UPF1 ITPR2 PPP2R1B FARSA AP2A2 UBR5 LMX1B SLC25A13 EIF2B3 NUP188 UQCRC1 ASCC3 DYNC1H1 | 1.41e-04 | 1440 | 134 | 16 | 30833792 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | P4HA2 USP29 MCM4 NXN USP6 PPP2R1B FARSA UBR5 ARHGEF10 SLC25A13 NUP188 ASCC3 LRRC15 | 1.43e-04 | 1005 | 134 | 13 | 19615732 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.46e-04 | 5 | 134 | 2 | 12629516 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.46e-04 | 5 | 134 | 2 | 11401426 | |
| Pubmed | Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease. | 1.46e-04 | 5 | 134 | 2 | 10547347 | |
| Pubmed | The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1 phosphorylation. | 1.46e-04 | 5 | 134 | 2 | 26841701 | |
| Pubmed | HSPG2 MAT2A PHB2 ATAD3C AP2A2 FHOD1 SLC25A13 EIF2B3 UQCRC1 ATP1A3 DYNC1H1 TANGO6 | 1.57e-04 | 878 | 134 | 12 | 37223481 | |
| Pubmed | Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. | 1.59e-04 | 70 | 134 | 4 | 35008187 | |
| Pubmed | 1.59e-04 | 131 | 134 | 5 | 28634551 | ||
| Pubmed | 1.66e-04 | 209 | 134 | 6 | 36779422 | ||
| Pubmed | 1.85e-04 | 304 | 134 | 7 | 32235678 | ||
| Pubmed | 1.90e-04 | 407 | 134 | 8 | 12693553 | ||
| Pubmed | 2.18e-04 | 76 | 134 | 4 | 27542412 | ||
| Pubmed | 2.19e-04 | 6 | 134 | 2 | 35247097 | ||
| Pubmed | 2.37e-04 | 534 | 134 | 9 | 35032548 | ||
| Pubmed | Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility. | 2.80e-04 | 33 | 134 | 3 | 17558393 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RNGTT WDR33 PHB2 MCM4 ZNF251 MAP3K1 UBR5 TBC1D1 NUP188 DYNC1H1 | 2.83e-04 | 670 | 134 | 10 | 22990118 |
| Pubmed | 3.06e-04 | 7 | 134 | 2 | 9452471 | ||
| Pubmed | 3.06e-04 | 7 | 134 | 2 | 30664872 | ||
| Pubmed | 3.16e-04 | 332 | 134 | 7 | 37433992 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 MAT2A PHB2 UTP23 MCM4 UPF1 BUD23 PLCD3 AP2A2 SLC25A13 CPSF1 DYNC1H1 | 3.19e-04 | 949 | 134 | 12 | 36574265 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 3.20e-04 | 84 | 134 | 4 | 25670202 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.20e-04 | 440 | 134 | 8 | 34244565 | |
| Pubmed | ATP6V1E1 UBQLN1 WDR33 MAT2A INSR MCM4 UPF1 FARSA AP2A2 SLC25A13 CPSF1 ASCC3 ATP1A3 DYNC1H1 | 3.38e-04 | 1247 | 134 | 14 | 27684187 | |
| Pubmed | 3.89e-04 | 453 | 134 | 8 | 29656893 | ||
| Pubmed | 3.95e-04 | 37 | 134 | 3 | 9798653 | ||
| Pubmed | 4.06e-04 | 8 | 134 | 2 | 31600777 | ||
| Pubmed | Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. | 4.06e-04 | 8 | 134 | 2 | 23459205 | |
| Pubmed | 4.06e-04 | 8 | 134 | 2 | 25907116 | ||
| Pubmed | TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. | 4.06e-04 | 8 | 134 | 2 | 15001576 | |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 4.12e-04 | 161 | 134 | 5 | 36398662 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 4.33e-04 | 580 | 134 | 9 | 35676659 | |
| Pubmed | 4.42e-04 | 251 | 134 | 6 | 27507650 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.43e-04 | 582 | 134 | 9 | 20467437 | |
| Pubmed | ZNF133 UBQLN1 MAT2A APC2 UBQLN4 WHAMM ZNF251 ZNF34 UBA7 ARHGEF10 PKD1 UQCRC1 ARHGAP21 DYNC1H1 | 4.55e-04 | 1285 | 134 | 14 | 35914814 | |
| Pubmed | 4.98e-04 | 40 | 134 | 3 | 30898150 | ||
| Pubmed | P4HA2 ATP6V1E1 COL12A1 EPPK1 UBQLN1 NCKAP1 MAT2A BUD23 UBR5 XXYLT1 HACL1 NUP188 UQCRC1 DYNC1H1 | 4.99e-04 | 1297 | 134 | 14 | 33545068 | |
| Pubmed | 5.21e-04 | 9 | 134 | 2 | 19015308 | ||
| Pubmed | 5.21e-04 | 9 | 134 | 2 | 18816447 | ||
| Pubmed | HSPG2 RNF213 UPF1 ARHGEF10 SLC25A13 DHRS2 ASCC3 CEP170B DYNC1H1 | 5.58e-04 | 601 | 134 | 9 | 33658012 | |
| Pubmed | 5.65e-04 | 263 | 134 | 6 | 12665801 | ||
| Pubmed | An essential role for Polycomb Repressive Complex 2 in the mouse ovary. | 5.75e-04 | 98 | 134 | 4 | 35084365 | |
| Pubmed | 5.78e-04 | 604 | 134 | 9 | 38803224 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 5.99e-04 | 607 | 134 | 9 | 39147351 | |
| Pubmed | 6.06e-04 | 608 | 134 | 9 | 16713569 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 6.17e-04 | 43 | 134 | 3 | 34672947 | |
| Cytoband | 6q16 | 8.41e-05 | 5 | 134 | 2 | 6q16 | |
| GeneFamily | Ubiquilin family | 2.48e-04 | 5 | 91 | 2 | 783 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 5.85e-06 | 197 | 128 | 8 | M5210 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.32e-07 | 179 | 129 | 7 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.32e-07 | 179 | 129 | 7 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.32e-07 | 179 | 129 | 7 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-06 | 194 | 129 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 1.38e-05 | 179 | 129 | 6 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 182 | 129 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 183 | 129 | 6 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 187 | 129 | 6 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 187 | 129 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.77e-05 | 187 | 129 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-05 | 191 | 129 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.06e-05 | 192 | 129 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.12e-05 | 193 | 129 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-05 | 194 | 129 | 6 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 196 | 129 | 6 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-05 | 197 | 129 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 197 | 129 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.44e-05 | 198 | 129 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 198 | 129 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 198 | 129 | 6 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 199 | 129 | 6 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.51e-05 | 199 | 129 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 199 | 129 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 199 | 129 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.51e-05 | 199 | 129 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.58e-05 | 128 | 129 | 5 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.48e-05 | 140 | 129 | 5 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-05 | 143 | 129 | 5 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.37e-05 | 149 | 129 | 5 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.37e-05 | 149 | 129 | 5 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.85e-05 | 151 | 129 | 5 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.15e-05 | 156 | 129 | 5 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.72e-05 | 158 | 129 | 5 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 159 | 129 | 5 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-04 | 159 | 129 | 5 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 163 | 129 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 163 | 129 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 86 | 129 | 4 | 79c4326df78f0a5b3ef13b2fb4e5074934536e35 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-04 | 165 | 129 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 166 | 129 | 5 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 166 | 129 | 5 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-04 | 167 | 129 | 5 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.30e-04 | 168 | 129 | 5 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.30e-04 | 168 | 129 | 5 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 168 | 129 | 5 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 168 | 129 | 5 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 169 | 129 | 5 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 171 | 129 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 171 | 129 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 174 | 129 | 5 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 175 | 129 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 176 | 129 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 176 | 129 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 177 | 129 | 5 | 6f3b254e56e722cc23495b49e99a4abce0243cb3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 178 | 129 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.74e-04 | 179 | 129 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 179 | 129 | 5 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 179 | 129 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 180 | 129 | 5 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-04 | 180 | 129 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 180 | 129 | 5 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 181 | 129 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-04 | 181 | 129 | 5 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-04 | 182 | 129 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 182 | 129 | 5 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-04 | 182 | 129 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-04 | 183 | 129 | 5 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-04 | 183 | 129 | 5 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 184 | 129 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.98e-04 | 184 | 129 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.03e-04 | 185 | 129 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 185 | 129 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 186 | 129 | 5 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.13e-04 | 187 | 129 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 188 | 129 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 188 | 129 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.19e-04 | 188 | 129 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 188 | 129 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.19e-04 | 188 | 129 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.19e-04 | 188 | 129 | 5 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.21e-04 | 102 | 129 | 4 | 0bbc6344d0baee47326a16a89773bb5c68a7b040 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.21e-04 | 102 | 129 | 4 | 11fbdb428824023603e9d4ee41e957ba84e7c29e | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 2.24e-04 | 189 | 129 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.24e-04 | 189 | 129 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-04 | 190 | 129 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 190 | 129 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 191 | 129 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 191 | 129 | 5 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 191 | 129 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 191 | 129 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 191 | 129 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-04 | 191 | 129 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 191 | 129 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.41e-04 | 192 | 129 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 192 | 129 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.78e-06 | 197 | 128 | 9 | 7365_UP | |
| Disease | Malformations of Cortical Development, Group II | 1.81e-05 | 2 | 126 | 2 | C1837249 | |
| Disease | Robinow syndrome, autosomal recessive | 1.81e-05 | 2 | 126 | 2 | C1849334 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.85e-05 | 145 | 126 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | periodontitis | 5.05e-05 | 223 | 126 | 7 | EFO_0000649 | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | coronary artery disease | P4HA2 FAT4 ERBB4 KCNH7 WDR33 MAT2A RNF213 MAP3K1 ZFPM2 STN1 RSBN1 GDPD5 PPP2R1B KCNJ13 ARHGAP21 | 1.80e-04 | 1194 | 126 | 15 | EFO_0001645 |
| Disease | Abnormal corpus callosum morphology | 2.68e-04 | 6 | 126 | 2 | C1842581 | |
| Disease | Abnormality of the eye | 3.75e-04 | 7 | 126 | 2 | C4316870 | |
| Disease | Gonadal Dysgenesis, 46,XY | 4.98e-04 | 8 | 126 | 2 | C0018054 | |
| Disease | Familial hyperinsulinism | 4.98e-04 | 8 | 126 | 2 | cv:C3888018 | |
| Disease | unipolar depression, bipolar disorder | 5.66e-04 | 156 | 126 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 6.39e-04 | 9 | 126 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | propionylcarnitine measurement | 6.39e-04 | 9 | 126 | 2 | EFO_0020942 | |
| Disease | insomnia measurement | 6.51e-04 | 443 | 126 | 8 | EFO_0007876 | |
| Disease | renal cell carcinoma | 7.73e-04 | 42 | 126 | 3 | EFO_0000681 | |
| Disease | Adenocarcinoma of large intestine | 7.77e-04 | 96 | 126 | 4 | C1319315 | |
| Disease | 46,XY partial gonadal dysgenesis | 9.70e-04 | 11 | 126 | 2 | C4510744 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | temporal arteritis | 1.16e-03 | 12 | 126 | 2 | EFO_1001209 | |
| Disease | health study participation | 1.53e-03 | 195 | 126 | 5 | EFO_0010130 | |
| Disease | hypoxanthine mesurement | 1.59e-03 | 14 | 126 | 2 | EFO_0010500 | |
| Disease | Leber congenital amaurosis | 2.09e-03 | 16 | 126 | 2 | cv:C0339527 | |
| Disease | myopia (is_implicated_in) | 2.09e-03 | 16 | 126 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Monogenic diabetes | 2.09e-03 | 16 | 126 | 2 | C3888631 | |
| Disease | transitional cell carcinoma (is_marker_for) | 2.50e-03 | 63 | 126 | 3 | DOID:2671 (is_marker_for) | |
| Disease | diabetic retinopathy | 2.80e-03 | 136 | 126 | 4 | EFO_0003770 | |
| Disease | Colorectal Carcinoma | 3.24e-03 | 702 | 126 | 9 | C0009402 | |
| Disease | Osteoarthritis of hip | 3.27e-03 | 20 | 126 | 2 | C0029410 | |
| Disease | Congenital diaphragmatic hernia | 3.60e-03 | 21 | 126 | 2 | C0235833 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 3.66e-03 | 72 | 126 | 3 | EFO_0008300 | |
| Disease | Leber Congenital Amaurosis | 3.95e-03 | 22 | 126 | 2 | C0339527 | |
| Disease | psychotic symptoms | 3.95e-03 | 74 | 126 | 3 | EFO_0005940 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRLAIIEYMPLLAGQ | 431 | P30154 | |
| PQRYLVIQGDDRMKL | 981 | Q15303 | |
| QTRMAGRALELLYLP | 36 | O43709 | |
| MPEGLSQQQVVRRYI | 411 | O15013 | |
| VSGMSLRPRVNYLQD | 196 | Q9UKH3 | |
| VYPILSRSLRQMAQG | 96 | Q9NZN9 | |
| IPQRPYMSLGSLRDQ | 546 | Q9UBJ2 | |
| EYLLRQSLRGAMLEP | 4226 | Q6V0I7 | |
| RLIEINPRMGGFYLR | 686 | A5YM72 | |
| RGPLLTQLYSLNMLV | 291 | P46597 | |
| VYVSANGRMVIQLRP | 836 | Q9Y4F5 | |
| QYLLLLLPEVDRQMG | 281 | Q9C0F0 | |
| EMALGPGREYRALQL | 211 | Q16790 | |
| RLEPNLQAQMYRLTL | 906 | O94973 | |
| RSLGNMYRLPATQEV | 946 | Q96SN8 | |
| VLQTLYQQRRHMGLP | 276 | A8MTL3 | |
| LSPMLNPLIYSLRNR | 281 | Q6IEU7 | |
| QRPDVVLMGAGYRLL | 631 | P98160 | |
| LILNDINPLGKYRMD | 2021 | Q14571 | |
| TMDIGRTVLQNYLPR | 401 | Q9UJ83 | |
| MVYGQKARLLSRPLR | 561 | Q7Z304 | |
| MVSAYPRQLESLIRL | 726 | P33991 | |
| PRLARLYPNMNLELQ | 326 | P18428 | |
| LMERLRQIQQQPSGY | 1981 | Q86YW9 | |
| MIIDRVNGQAVPRYL | 346 | O60942 | |
| AGSEYQRPIIQLMRT | 1076 | Q9NS40 | |
| SSRRLQRMPVQYILG | 101 | Q9Y5R4 | |
| SMLQIPRNRNLGNYA | 176 | Q8N6Y2 | |
| VQYMQDRGAVLPIRV | 186 | P31153 | |
| QLRLLFDQAYLMRPS | 486 | Q9ULI0 | |
| LVQMQRKGAPRVLLY | 646 | P51511 | |
| EGMYPARLLDSIQLL | 216 | Q8WW38 | |
| LLVRENGTMEIYQLP | 786 | Q10570 | |
| NPLIYSLRNRDVMGA | 286 | Q8NHC8 | |
| LNPLIYSLRNREVMG | 286 | Q96R30 | |
| MFLTVRGLKRIDPNY | 511 | O94830 | |
| PLLSQRYRRMVTKDG | 11 | O60928 | |
| TILNDRGQGVLIRMY | 16 | P55160 | |
| RISQQMDGLAPYRLK | 61 | Q8WY64 | |
| RLGGIRSYNPEQIML | 521 | Q8WTR4 | |
| LGLYNLMNITRGSVR | 131 | P06213 | |
| RPNAQELPSMYQRLG | 111 | Q99623 | |
| PIEQLPDYNRIRSGM | 461 | P31930 | |
| ALISLQMVYPRRNLS | 206 | Q9Y2A7 | |
| SLLDARVMTPYLQQR | 181 | Q6ZVX9 | |
| YNLILDRETQKLMGP | 406 | Q7Z442 | |
| LMRLQDTYRLDPGTI | 136 | O15460 | |
| REIGNIIRMYQSRPG | 1086 | Q96JP2 | |
| APGQSLYERLSQRML | 16 | O75344 | |
| RMLSPRNQLIRVILY | 431 | O94856 | |
| VLGIRPIRLQVQYRM | 701 | Q92900 | |
| LGLYMEANRQVPKLL | 316 | Q9NR50 | |
| DPLNLALRRYAGMTL | 456 | O95996 | |
| IYAIRNPNISMLLGR | 386 | Q8IZ08 | |
| REESLPNLLQYVRMP | 211 | Q53G59 | |
| LVPRYRLQLLGIACM | 346 | P41002 | |
| TLMRGLARNVQVYNP | 1931 | Q99715 | |
| VSGMSLRPRVNYLQD | 86 | P61566 | |
| VSGMSLRPRVNYLQD | 86 | P61567 | |
| GLRANIIRSYLMDPI | 3546 | Q8WXX0 | |
| PGQEERARLVRMYLN | 301 | Q5T2N8 | |
| VSGMSLRPRVNYLQD | 196 | P61565 | |
| VSGMSLRPRVNYLQD | 86 | Q9HDB8 | |
| TLMPYTRLTQLNLDR | 66 | P07359 | |
| NRYLLVMKGAPERIL | 491 | P13637 | |
| QIYGTFNRAMLRLIP | 2746 | Q14204 | |
| GPELSRRIYLQMTTL | 546 | Q96AY2 | |
| LGYTPQAAREVRIMQ | 961 | Q9Y613 | |
| VYLPAMAFQGLLRVR | 171 | Q6NUI6 | |
| IRLQELIMAPSRYNI | 186 | Q13003 | |
| PYSLRRLTGLEVQNM | 996 | Q14147 | |
| LLLSQLLPYMENRRG | 151 | Q13268 | |
| LLPYMENRRGAVILV | 156 | Q13268 | |
| RPLYILRLGQMDTKG | 326 | O43304 | |
| YLEGEAVRLSRQLPM | 876 | P54277 | |
| DPNALNGMLRYRIVS | 296 | P19022 | |
| MARSSPYLRQLQGPL | 1 | Q8NG08 | |
| LQYLVGMLRQSPALT | 801 | P59044 | |
| PRQLMEVSQLLRLYQ | 801 | Q8N137 | |
| NMGLAVQYLDPRGRL | 321 | Q99759 | |
| PLQVLMRRSQRNYLE | 2156 | P98161 | |
| NVISGIPIYRVMDRQ | 71 | P12694 | |
| PLIYTLRNSEMRNAI | 281 | Q8NH83 | |
| VMRARLYLLQQIGPN | 311 | Q13233 | |
| QLCRLNLGMQEYRVP | 316 | Q5VWQ0 | |
| GRIQLREQLPRYLMG | 41 | Q9BRU9 | |
| NIQIARMLELPTIYR | 161 | Q9H668 | |
| KFSPYLGQMINLRRL | 251 | P78395 | |
| LLNVYPDGLTGRERM | 241 | Q3MII6 | |
| LERPTMIKYGINNIR | 461 | Q9Y285 | |
| VLRLYENRLTDIPMG | 201 | Q8TF66 | |
| GQVRYLQLCPRLAML | 176 | Q8IYG6 | |
| LNRLYGIQGIPTLIM | 266 | Q6DKJ4 | |
| QLYILVNGFLRPLRM | 261 | O14827 | |
| RLLGLMRPSSLRQYL | 556 | Q8IXR5 | |
| RLLPSGQRLSLYQAM | 936 | P58107 | |
| LYQAMRQKLLGPRVA | 946 | P58107 | |
| PYLGQMRNLRKLVLS | 226 | Q5VT98 | |
| NPGNSVRLMPLRYDL | 2236 | Q9NT68 | |
| PTLGMEQGRRLLLSY | 111 | Q9BR26 | |
| YLLQPFRAMREVATL | 241 | Q8TF30 | |
| QEYTIARSNPLILMR | 266 | Q01974 | |
| GKLPIAMRALTNYQR | 251 | Q09428 | |
| MIRILGLSATLPNYL | 641 | Q8N3C0 | |
| ILFQLADLYEPRGRM | 271 | Q9UJS0 | |
| MTRDLYQGLLLQRVP | 2346 | Q63HN8 | |
| LPRCYLLMRQPGLNT | 811 | Q7RTX0 | |
| LSPAQRALYRSVMLE | 31 | P17023 | |
| RMLPDYFNRRIIGAL | 601 | Q0IIM8 | |
| SRQLYVLGSPAMQRI | 16 | P41226 | |
| QLTRVYPLGLRMNSA | 581 | Q8N3E9 | |
| NLESIPGGYNALRRM | 261 | Q9UMX0 | |
| GLRKQYRPDMIILQI | 921 | Q86TI0 | |
| LSLRRYPGSDRIMLQ | 2526 | Q6ZS81 | |
| RGALRDMLDQVYQPL | 256 | Q9C0B7 | |
| TRNVKMGDPLQAYRL | 811 | Q9HBJ7 | |
| LLISQAMRYLRDPAV | 1661 | Q5SRE5 | |
| MKLIYQGRLLQDPAR | 211 | Q71RG4 | |
| KYLLSDLGPQERMQI | 871 | Q9NRE2 | |
| RLLSPAQRTLYREVM | 16 | P52736 | |
| QLGPQQRALYRDVML | 31 | Q9BRH9 | |
| QIASYPLALVRTRMQ | 391 | Q9BV35 | |
| MIYQLPTRVRGSLRA | 1216 | A6NGW2 | |
| LQGLYQLLEPRMIVR | 121 | P36543 | |
| MRDRYNLNLLPGMSE | 411 | Q9C0J8 | |
| LQRMAPGYGDVRLSL | 296 | A5PLN9 | |
| VLTQPGRAYRMEIQV | 236 | Q5T5U3 | |
| NLESIPGGYNALRRM | 271 | Q9NRR5 | |
| LDGTTPVRYGLRLNM | 726 | P35125 | |
| LNPAQRALYRAVMLE | 41 | Q0VGE8 | |
| ALGERLYPRVQAMQP | 2396 | O95071 | |
| ILLRGDLPGNSLRYM | 436 | Q9NX78 | |
| NLEAMRQSPLYSRLL | 296 | Q8NBI6 | |
| RLGPAQRGLYRDVML | 51 | Q8IZ26 | |
| LSPEGYQLPQNRRMT | 361 | Q9H6D3 | |
| LQARVGNPIDRLYSM | 381 | O60663 |